CAS 105760-98-3

NK-611 hydrochloride

Description:

NK-611 hydrochloride, with the CAS number 105760-98-3, is a chemical compound that belongs to the class of selective serotonin reuptake inhibitors (SSRIs). It is primarily researched for its potential applications in the treatment of various psychiatric disorders, particularly depression and anxiety. The compound exhibits a mechanism of action that involves the modulation of serotonin levels in the brain, which can enhance mood and emotional well-being. NK-611 hydrochloride is characterized by its solubility in water, which facilitates its formulation in pharmaceutical preparations. Additionally, it may possess a favorable pharmacokinetic profile, contributing to its efficacy and safety in clinical settings. As with many SSRIs, potential side effects may include gastrointestinal disturbances, changes in weight, and effects on sexual function. Ongoing research continues to explore its therapeutic potential and optimize its use in clinical practice. However, as with any pharmaceutical agent, it is essential to consider individual patient factors and conduct thorough evaluations before prescribing.

Formula: C₃₁H₃₇NO₁₂·ClH

InChI: InChI=1/C31H37NO12.ClH/c1-13-38-11-22-29(42-13)27(34)25(32(2)3)31(43-22)44-28-16-9-19-18(40-12-41-19)8-15(16)23(24-17(28)10-39-30(24)35)14-6-20(36-4)26(33)21(7-14)37-5;/h6-9,13,17,22-25,27-29,31,33-34H,10-12H2,1-5H3;1H

InChI key: InChIKey=PYLTTZZOZBYUEI-YRQLFVATSA-N

SMILES: O=C1[C@@]2([C@@H](C=3C([C@@H](O[C@H]4[C@H](N(C)C)[C@@H](O)[C@]5([C@](O4)(CO[C@@H](C)O5)[H])[H])[C@]2(CO1)[H])=CC6=C(C3)OCO6)C7=CC(OC)=C(O)C(OC)=C7)[H].Cl

Synonyms:

• (5R-(5alpha,5abeta,8aalpha,9beta))-9-((2-Deoxy-2-(dimethylamino)-4,6-O-ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one hydrochloride
• 9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 2-deoxy-2-(dimethylamino)-4,6-O-ethylidenehexopyranoside hydrochloride (1:1)
• Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[[2-deoxy-2-(dimethylamino)-4,6-O-(1R)-ethylidene-β-<span class="text-smallcaps">D</span>-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, hydrochloride (1:1), (5R,5aR,8aR,9S)-
• Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[[2-deoxy-2-(dimethylamino)-4,6-O-(1R)-ethylidene-β-<span class="text-smallcaps">D</span>-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, hydrochloride, (5R,5aR,8aR,9S)-
• Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[[2-deoxy-2-(dimethylamino)-4,6-O-ethylidene-β-<span class="text-smallcaps">D</span>-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, hydrochloride, [5R-[5α,5aβ,8aα,9β(R*)]]-
• Nk 611
• Pyrano[3,2-d]-1,3-dioxin, furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one deriv.
• Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[[2-deoxy-2-(dimethylamino)-4,6-O-ethylidene-β-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, hydrochloride, [5R-[5α,5aβ,8aα,9β(R*)]]-
• Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[[2-deoxy-2-(dimethylamino)-4,6-O-(1R)-ethylidene-β-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, hydrochloride (1:1), (5R,5aR,8aR,9S)-
• Furo[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[[2-deoxy-2-(dimethylamino)-4,6-O-(1R)-ethylidene-β-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, hydrochloride, (5R,5aR,8aR,9S)-
• NK-611 hydrochloride

NK 611

CAS: 105760-98-3

NK 611 is a new semisynthetic analogue of etoposide and has been found to be more potent against several cancer cell lines in vitro than etoposide.

Formula: C₃₁H₃₈ClNO₁₂

Color and Shape: Solid

Molecular weight: 652.09

Ref: TM-T33695